ADI
51
-3
BF.B
33
-4
URBN
50
-2
HCP
62
-8
MU
36
-6
O
24
2
GE
72
4
BWA
48
-5
TSN
42
3
SPG
63
7
DG
6
-4
GME
70
2
ROK
64
-2
DNB
82
-2
SWKS
51
-2
HOG
36
-3
WU
34
-2
HST
59
7
FCX
57
-2
UAL
83
-2
ADI
51
-3
BF.B
33
-4
URBN
50
-2
HCP
62
-8
MU
36
-6
O
24
2
GE
72
4
BWA
48
-5
TSN
42
3
SPG
63
7
DG
6
-4
GME
70
2
ROK
64
-2
DNB
82
-2
SWKS
51
-2
HOG
36
-3
WU
34
-2
HST
59
7
FCX
57
-2
UAL
83
-2
Financhill
Back

Verrica Pharmaceuticals Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40

VRCA
Verrica Pharmaceuticals

Last Price:
1.22
Seasonality Move:
50.53%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

Verrica Pharmaceuticals Price Quote

$1.22
+0.11 (+9.91%)
(Updated: November 27, 2024 at 5:55 PM ET)

Verrica Pharmaceuticals Key Stats

Sell
40
Verrica Pharmaceuticals (VRCA) is a Sell
Day range:
$0.97 - $1.15
52-week range:
$0.70 - $11.41
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
5.61
P/B ratio:
0%
Volume:
1.3M
Avg. volume:
764.3K
1-year change:
-70.63%
Market cap:
$100.5M
Revenue:
$5.1M
EPS:
$-1.84

How Much Does Verrica Pharmaceuticals Make?

Is Verrica Pharmaceuticals Growing As A Company?

Data Unavailable

Verrica Pharmaceuticals Stock Price Performance

What Is Verrica Pharmaceuticals 52-Week High & Low?

Verrica Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Verrica Pharmaceuticals?

Is Verrica Pharmaceuticals Cash Flow Positive?

  • What Is VRCA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$59.4M
  • What Is Verrica Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.7M
  • What Is Verrica Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$254K

Verrica Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    VRCA return on invested capital is -184.44%
  • What Is Verrica Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -128.78%
  • What Is VRCA Return On Equity?
    ROE is a measure of profitability and is -2619.46%

Verrica Pharmaceuticals Earnings Date & Stock Price

Verrica Pharmaceuticals Competitors

Verrica Pharmaceuticals Dividend Yield

Verrica Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -26.45%
Revenue: 0% -133.85%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 4
Sell Recommendations: 0
Price Target: 6.33
Upside from Last Price: 470.57%

Major Shareholders

  • How many VRCA shares are owned by institutional investors?
    22.7M VRCA shares are owned by institutional investors
  • How many VRCA shares are owned by insiders?
    11.7M VRCA shares are owned by insiders